Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Medable is bringing generative AI into its clinical trial platform in hopes that the tech will reduce the burden of ...

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...

In this week’s episode of “Podnosis,” we’re diving deep into the current landscape of clinical trials in the U.S.

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

The two-day event will see industry experts from across the clinical trial space holding talks on subjects from AI to ...